A Phase 1, Open-Label, Dose-Escalation Study of L-DOS47 in Combination With Pemetrexed Plus Carboplatin in Patients With Stage IV Recurrent or Metastatic Nonsquamous NSCLC-Reference-Cited by-同舟云学术

A Phase 1, Open-Label, Dose-Escalation Study of L-DOS47 in Combination With Pemetrexed Plus Carboplatin in Patients With Stage IV Recurrent or Metastatic Nonsquamous NSCLC

Published:2022-11 Issue:11 Volume:3 Page:100408
ISSN:2666-3643
Container-title:JTO Clinical and Research Reports
language:en
Short-container-title:JTO Clinical and Research Reports

Author:

Piha-Paul Sarina,Simon George,Belani Chandra P.,Chao Heman,Gaspar Kim,Lee Brenda,Dowlati Afshin

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference22 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

2. Therapy for stage IV non–small-cell lung cancer with driver alterations: ASCO and OH (CCO) joint guideline update;Hanna;J Clin Oncol,2021

3. Therapy for stage IV non–small-cell lung cancer without driver alterations: ASCO and OH (CCO) joint guideline update;Hanna;J Clin Oncol,2020

4. Role of hypoxic stress in regulating tumor immunogenicity, resistance and plasticity;Terry;Int J Mol Sci,2018

5. Reexamining cancer metabolism: lactate production for carcinogenesis could be the purpose and explanation of the Warburg Effect;San-Millán;Carcinogenesis,2016

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. L-DOS47 Elevates Pancreatic Cancer Tumor pH and Enhances Response to Immunotherapy;Biomedicines;2024-02-19

2. Antibodies toward Na+,HCO3–-cotransporter NBCn1/SLC4A7 block net acid extrusion and cause pH-dependent growth inhibition and apoptosis in breast cancer;British Journal of Cancer;2024-02-03

3. Current status and future expectations of nanobodies in oncology trials;Expert Opinion on Investigational Drugs;2023-08-03